Print

TEVA AND ACTIVE BIOTECH TO INITIATE PIVOTAL PHASE III TRIAL PROGRAM OF ORAL LAQUINIMOD FOR RELAPSING MULTIPLE SCLEROSIS

2007-06-07

Contacts:

pdfTeva and Active Biotech to Initiate Pivotal Phase III Trials of Laquinimod for MS



Back